racemetirosine has been researched along with Aura in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Excerpt | Relevance | Reference |
---|---|---|
"We have investigated the influence of central noradrenergic and dopaminergic systems on the susceptibility of rats to seizures in the kainic acid (KA)-model of epilepsy." | 3.67 | Kainic acid-induced seizures: potentiation by alpha-methyl-p-tyrosine. ( Baran, H; Hornykiewicz, O; Hörtnagl, H, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baran, H | 1 |
Hörtnagl, H | 1 |
Hornykiewicz, O | 1 |
1 other study available for racemetirosine and Aura
Article | Year |
---|---|
Kainic acid-induced seizures: potentiation by alpha-methyl-p-tyrosine.
Topics: alpha-Methyltyrosine; Animals; Clonidine; Diazepam; Dopamine; Epilepsy; Kainic Acid; Male; Methyltyr | 1989 |